Neoadjuvant toripalimab plus axitinib for clear cell renal cell carcinoma with inferior vena cava tumor thrombus: NEOTAX, a phase 2 study.
Gu L, Peng C, Liang Q, Huang Q, Lv D, Zhao H, Zhang Q, Zhang Y, Zhang P, Li S, Xu J, Chen L, Xie Y, Li J, Guo G, Zhang X, Wang B, Ma X.
Gu L, et al. Among authors: peng c.
Signal Transduct Target Ther. 2024 Oct 4;9(1):264. doi: 10.1038/s41392-024-01990-2.
Signal Transduct Target Ther. 2024.
PMID: 39362847
Free PMC article.
Clinical Trial.